{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:21:49Z","timestamp":1795040509228,"version":"4.10.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer is the commonest cancer diagnosed globally and the second leading cause of cancer-related mortality among women younger than 40\u00a0years. This study comparatively reviewed the demographic, pathologic and molecular features of Early-Onset Breast Cancer (EOBC) reported in Ghana in relation to Late Onset Breast Cancer (LOBC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A descriptive, cross-sectional design was used, with purposive sampling of retrospective histopathology data from 2019 to 2021. Reports of core or incision biopsy, Wide Local Excision or Mastectomy with or without axillary lymph node dissection specimen and matched immunohistochemistry reports were merged into a single file and analysed with SPSS v. 20.0. Descriptive statistics of frequencies and percentages were used to describe categorical variables. Cross-tabulation and chi-square test was done at a 95% confidence interval with significance established at\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2418 cases were included in the study with 20.2% (488 cases) being EOBCs and 79.8% (1930 cases) being LOBCs. The median age at diagnosis was 34.66 (IQR: 5.55) in the EOBC group (&lt;\u200940\u00a0years) and 54.29 (IQR: 16.86) in the LOBC group (\u2265\u200940\u00a0years). Invasive carcinoma\u2014No Special Type was the commonest tumour type with grade III tumours being the commonest in both categories of patients. Perineural invasion was the only statistically significant pathologic parameter with age. EOBC was associated with higher DCIS component (24.8% vs 21.6%), lower hormone-receptor-positive status (52.30% vs 55.70%), higher proliferation index (Ki-67\u2009&gt;\u200920: 82.40% vs 80.30%) and a higher number of involved lymph nodes (13.80% vs 9.00%). Triple-Negative Breast cancer (26.40% vs 24.30%) was the most predominant molecular subtype of EOBC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EOBCs in our setting are generally more aggressive with poorer prognostic histopathological and molecular features when compared with LOBCs. A larger study is recommended to identify the association between relevant pathological features and early onset breast cancer in Ghana. Again, further molecular and genetic studies to understand the molecular genetic drivers of the general poorer pathological features of EOBCs and its relation to patient outcome in our setting is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-022-02142-w","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T04:03:13Z","timestamp":1672718593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinicopathologic characteristics of early-onset breast cancer: a comparative analysis of cases from across Ghana"],"prefix":"10.1186","volume":"23","author":[{"given":"Patrick Kafui","family":"Akakpo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Gustav","family":"Imbeah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Edusei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Naporo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi","family":"Ulzen-Appiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Nat","family":"Clegg-Lamptey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dedey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Nsaful","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Affram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Wiafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nortey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Sheriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forster","family":"Amponsah-Manu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwabena","family":"Agbedinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Mawunyo","family":"Jiagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"2142_CR1","unstructured":"GLOBOCAN 2020: Global Cancer Observatory. International Agency for Research on Cancer 2022. https:\/\/gco.iarc.fr\/today\/online-analysis-pie?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=total&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0. Last accessed on 30th Nov 2022."},{"issue":"11","key":"2142_CR2","doi-asserted-by":"publisher","first-page":"e0187638","DOI":"10.1371\/journal.pone.0187638","volume":"12","author":"A Hironaka-Mitsuhashi","year":"2017","unstructured":"Hironaka-Mitsuhashi A, Matsuzaki J, Takahashi R, Yoshida M, Nezu Y, Yamamoto Y, Shiino S, Kinoshita T, Ushijima T, Hiraoka N. A tissue microRNA signature that predicts the prognosis of breast cancer in young women. PLoS ONE. 2017;12(11):e0187638.","journal-title":"PLoS ONE"},{"issue":"4","key":"2142_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-014-0427-5","volume":"16","author":"HA Azim","year":"2014","unstructured":"Azim HA, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res. 2014;16(4):1\u20139.","journal-title":"Breast Cancer Res"},{"key":"2142_CR4","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.3389\/fonc.2021.797505","volume":"11","author":"A Andrikopoulou","year":"2022","unstructured":"Andrikopoulou A, Chatzinikolaou S, Kyriopoulos I, Bletsa G, Kaparelou M, Liontos M, Dimopoulos M, Zagouri F. The mutational landscape of early-onset breast cancer: a next-generation sequencing analysis. Front Oncol. 2022;11:5284.","journal-title":"Front Oncol"},{"key":"2142_CR5","first-page":"419","volume":"7","author":"C Reyna","year":"2014","unstructured":"Reyna C, Lee MC. Breast cancer in young women: special considerations in multidisciplinary care. J Multidiscip Healthc. 2014;7:419.","journal-title":"J Multidiscip Healthc"},{"key":"2142_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3645308","author":"F Naku Ghartey Jnr","year":"2016","unstructured":"Naku Ghartey Jnr F, Anyanful A, Eliason S, Mohammed Adamu S, Debrah S. Pattern of breast cancer distribution in Ghana: a survey to enhance early detection, diagnosis, and treatment. Int J Breast Cancer. 2016. https:\/\/doi.org\/10.1155\/2016\/3645308.","journal-title":"Int J Breast Cancer"},{"issue":"13","key":"2142_CR7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/jnci\/djt134","volume":"105","author":"E Copson","year":"2013","unstructured":"Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G. Prospective observational study of breast cancer treatment outcomes for UK women aged 18\u201340 years at diagnosis: the POSH study. J Natl Cancer Inst. 2013;105(13):978\u201388.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2142_CR8","first-page":"497","volume":"57","author":"I Eri\u0107","year":"2018","unstructured":"Eri\u0107 I, Petek Eri\u0107 A, Kristek J, Kopriv\u010di\u0107 I, Babi\u0107 M. Breast cancer in young women: pathologic and immunohistochemical features. Acta Clin Croat. 2018;57(3):497\u2013501.","journal-title":"Acta Clin Croat"},{"issue":"3","key":"2142_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/genes12030372","volume":"12","author":"A Siddig","year":"2021","unstructured":"Siddig A, Tengku Din TADA-A, Mohd Nafi SN, Yahya MM, Sulong S, Wan Abdul Rahman WF. The unique biology behind the early onset of breast cancer. Genes. 2021;12(3):372.","journal-title":"Genes"},{"key":"2142_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mrrev.2017.08.001","volume":"774","author":"L G\u00f3mez-Flores-Ramos","year":"2017","unstructured":"G\u00f3mez-Flores-Ramos L, \u00c1lvarez-G\u00f3mez RM, Villarreal-Garza C, Wegman-Ostrosky T, Mohar A. Breast cancer genetics in young women: what do we know? Mutat Res Rev Mutat Res. 2017;774:33\u201345.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"4","key":"2142_CR11","first-page":"181","volume":"69","author":"L G\u00f3mez-Flores-Ramos","year":"2017","unstructured":"G\u00f3mez-Flores-Ramos L, Castro-S\u00e1nchez A, Pe\u00f1a-Curiel O, Mohar-Betancourt A. Molecular biology in young women with breast cancer: From tumor gene expression to DNA mutations. Rev Investig Clin. 2017;69(4):181\u201392.","journal-title":"Rev Investig Clin"},{"issue":"11","key":"2142_CR12","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1245\/s10434-015-4399-1","volume":"22","author":"J Kim","year":"2015","unstructured":"Kim J, Han W, Jung S-Y, Park YH, Moon H-G, Ahn SK, Lee JW, Kim MK, Kim JJ, Lee ES. The value of Ki67 in very young women with hormone receptor-positive breast cancer: retrospective analysis of 9,321 Korean women. Ann Surg Oncol. 2015;22(11):3481\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2142_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/bjc.2012.219","volume":"107","author":"D Morrison","year":"2012","unstructured":"Morrison D, Rahardja D, King E, Peng Y, Sarode V. Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer. Br J Cancer. 2012;107(2):382\u20137.","journal-title":"Br J Cancer"},{"issue":"9","key":"2142_CR14","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates A, Gelber R, Piccart-Gebhart M, Th\u00fcrlimann B, Senn H-J, Albain KS, Andr\u00e9 F, Bergh J. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24(9):2206\u201323.","journal-title":"Ann Oncol"},{"issue":"5","key":"2142_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr2647","volume":"12","author":"CA Gabriel","year":"2010","unstructured":"Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res. 2010;12(5):1\u201310.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2142_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10549-011-1872-9","volume":"131","author":"L Collins","year":"2012","unstructured":"Collins L, Marotti J, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel E, Schapira L, Come S, Winer E. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012;131(3):1061\u20136.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2142_CR17","doi-asserted-by":"publisher","first-page":"e1373","DOI":"10.1371\/journal.pone.0001373","volume":"3","author":"CK Anders","year":"2008","unstructured":"Anders CK, Acharya CR, Hsu DS, Broadwater G, Garman K, Foekens JA, Zhang Y, Wang Y, Marcom K, Marks JR. Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. PLoS ONE. 2008;3(1):e1373.","journal-title":"PLoS ONE"},{"issue":"20","key":"2142_CR18","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","volume":"26","author":"CK Anders","year":"2008","unstructured":"Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324\u201330.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2142_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10549-021-06097-8","volume":"186","author":"EM Jiagge","year":"2021","unstructured":"Jiagge EM, Ulintz PJ, Wong S, McDermott SP, Fossi SI, Suhan TK, Hoenerhoff MJ, Bensenhaver JM, Salem B, Dziubinski M. Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry. Breast Cancer Res Treat. 2021;186(2):391\u2013401.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"2142_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10549-017-4408-0","volume":"166","author":"KE Lukong","year":"2017","unstructured":"Lukong KE, Ogunbolude Y, Kamdem JP. Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants. Breast Cancer Res Treat. 2017;166(2):351\u201365.","journal-title":"Breast Cancer Res Treat"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02142-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-02142-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02142-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T04:03:37Z","timestamp":1672718617000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-02142-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2142"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-02142-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1971697\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical Approval was sort from the Ethical Review Committees (ERC) of the Cape Coast Teaching Hospital (CCTHERC\/EC\/2020\/047), Komfo Anokye Teaching Hospital (KATH IRB\/AP\/052\/20)), Korle Bu Teaching Hospital (KBTH-IRB\/000169\/2021), and the Tamale Teaching Hospital (TTH\/R&D\/SR\/20\/95) as part of a broader study into the \u2018Genetic and Molecular determinants of Breast Cancer Disparity among Africans.\u2019- Precision Medicine for Aggressive Breast Cancer (PMABC) in partnership with the Jiagge Laboratory at the Henry Ford Cancer Center, Detroit, Michigan, USA. The ethical clearance obtained from ERC of the Cape Coast Teaching Hospital, Komfo Anokye Teaching Hospital, Korle Bu Teaching Hospital and the Tamale Teaching Hospital indicated that informed consent was not required for the use of such secondary data (retrospective data) for as long as personal identifies were omitted from the data. All methods were carried out in accordance with the Declaration of Helsinki and other relevant ethical guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}